Maxim Group Downgrades Kiora Pharmaceuticals to Hold

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

Maxim Group analyst Michael Okunewitch downgrades Kiora Pharmaceuticals (NASDAQ:KPRX) from Buy to Hold.

Total
0
Shares
Related Posts